BioSpace News Archive

illuminate.health, a digital health assistant platform designed to help people live healthier, today announced the general availability of Recovery Coach, an artificial intelligence (AI)-powered digital health assistant and evidence-based addiction treatment resource, to virtually support patients in their journey towards substance use disorder (SUD) recovery.

The inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum successfully concluded in Shanghai on July 17, at which more than 700 authoritative researchers and corporate leaders shared insights on the future growth of the cell and gene industry.

Novum Pharmaceutical Research Services announced an expansion of its services in North America. Novum, one of the world’s leading Contract Research Organizations for almost fifty years, has consolidated Lambda Therapeutic Research’s Toronto, Canada clinic and bioanalytical laboratory into Novum operations.

AlgoMedica, Inc., the developer of PixelShine®, is pleased to announce they have signed a distribution agreement with Radiology Oncology Systems, a global provider of radiation oncology and diagnostic imaging equipment, accessories and related services.

Rapid Technologies, a Premier ServiceNow partner, recently completed a ServiceNow modernization project for San Diego-based Sanford Burnham Prebys Medical Discovery Institute.

Barclays announces the appointment of Connie Chiang as a Managing Director in Biotech Investment Banking. Ms. Chiang will be based in New York, and will report to Rick Landgarten, Global Head of Healthcare & Real Estate Groups at Barclays.

Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended June 30, 2020.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2020 second quarter financial results on Tuesday, August 4, 2020, after the close of the financial markets

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will hold a conference call on Tuesday, July 28, 2020, to discuss the Company’s Second Quarter 2020 financial results.

Boston Scientific Corporation (NYSE: BSX) announced it has received U.S. Food and Drug Administration (FDA) approval for the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device.